Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy

Abstract

CART-related GI-AEs occur in 15% of patients treated with CART. These symptoms are typically mild and self-limiting, requiring only symptomatic treatment. Nevertheless, CART may, in rare cases, lead to refractory colitis.